Global Oral Rehydration Salts (ORS) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oral Rehydration Salts (ORS) Market Research Report 2024
Oral rehydration salts (ORS) are a mixture of electrolytes (salts), and carbohydrates (in the form of sugar), which are dissolved in water. They are used to replace salts and water that the body loses when you have dehydration caused by gastroenteritis, diarrhoea, or vomiting.
According to Mr Accuracy reports’s new survey, global Oral Rehydration Salts (ORS) market is projected to reach US$ 826.2 million in 2034, increasing from US$ 646.1 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Rehydration Salts (ORS) market research.
The classification of Oral Rehydration Salt includes Powder, Tablet and Solution. Tablets accounted for a share of 48% in the global Oral Rehydration Salt market.
Oral Rehydration Salt is widely used for Children Diarrhea, Adult Diarrhea and Other. In Oral Rehydration Salt market, the Adult Diarrhea holds an important share in terms of Application.
North America is the largest consumption place, with a consumption market share nearly 35%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 30%.
Market competition is intense. Abbott, Sanofi, Otsuka Pharmaceutical, AmJan, FDC and Prestige Brands, etc. are the leaders of the industry, with high-end customers. The top five manufacturers held 60% of the market, in terms of Oral Rehydration Salt revenue.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Rehydration Salts (ORS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott
Sanofi
Jianas Brothers
Trifecta Pharmaceuticals
Otsuka Pharmaceutical
Watson Pharma
FDC Limited
Multichem NZ Ltd
Shanghai Trifecta Pharma
Tianjin Teda Steyuan Pharm
ZouPing YiKang Group
Segment by Type
Solutions
Powders
Infants
Children
Adults
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Oral Rehydration Salts (ORS) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Oral Rehydration Salts (ORS) market is projected to reach US$ 826.2 million in 2034, increasing from US$ 646.1 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Rehydration Salts (ORS) market research.
The classification of Oral Rehydration Salt includes Powder, Tablet and Solution. Tablets accounted for a share of 48% in the global Oral Rehydration Salt market.
Oral Rehydration Salt is widely used for Children Diarrhea, Adult Diarrhea and Other. In Oral Rehydration Salt market, the Adult Diarrhea holds an important share in terms of Application.
North America is the largest consumption place, with a consumption market share nearly 35%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 30%.
Market competition is intense. Abbott, Sanofi, Otsuka Pharmaceutical, AmJan, FDC and Prestige Brands, etc. are the leaders of the industry, with high-end customers. The top five manufacturers held 60% of the market, in terms of Oral Rehydration Salt revenue.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Rehydration Salts (ORS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Sanofi
Jianas Brothers
Trifecta Pharmaceuticals
Otsuka Pharmaceutical
Watson Pharma
FDC Limited
Multichem NZ Ltd
Shanghai Trifecta Pharma
Tianjin Teda Steyuan Pharm
ZouPing YiKang Group
Segment by Type
Solutions
Powders
Segment by Application
Infants
Children
Adults
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Oral Rehydration Salts (ORS) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices